Evidence map›Paper›PMID 34729311›Full record

ArticleActa pharmaceutica Sinica. B2021

Bioresponsive micro-to-nano albumin-based systems for targeted drug delivery against complex fungal infections.

Liting Cheng, Miao-Miao Niu, Tong Yan, Zhongyi Ma, Kexin Huang, Ling Yang, Xin Zhong, Chong Li

Open access · diamondAbstract read
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. [Application of drug delivery microspheres in cancer therapy].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2024
    Review
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Liting ChengMedical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
Miao-Miao NiuKey Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education), China Pharmaceutical University, Nanjing 210009, China.
Tong YanMedical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
Zhongyi MaMedical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
Kexin HuangMedical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
Ling YangMedical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
Xin ZhongMedical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
Chong LiMedical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
Southwest University · CNChina Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a typical human pathogenic fungus,

Indexed as

AlbuminAmB, amphotericin BBBB, blood‒brain barrierBSA, bovine serum albuminComplex fungal infectionDDS, drug delivery systemIME, infectious microenvironmentMicroenvironment responsiveMMP-3MMP-3, matrix metalloproteinase 3MTN, micro-to-nanoNP, nanoparticlePEG, polyethylene glycolPMVECs, pulmonary microvascular endothelial cellsRFP, red fluorescent proteinSize-tunable strategySPARCSPARC, secreted protein acidic and rich in cysteine

Identifiers

PMID34729311
PMCPMC8546853
OpenAlexW3163345621

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.